Immunoadsorption in Patients With Severe Systemic Sclerosis

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03629002` - BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA
Terminated	`NCT00377455` - Placebo Controlled Trial of Bosentan in Scleroderma Patients	Phase 2
Completed	`NCT00318188` - Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis	N/A
Completed	`NCT00278525` - Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma	Phase 2
Completed	`NCT03575156` - Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis	N/A
Active, not recruiting	`NCT01413100` - Scleroderma Treatment With Autologous Transplant (STAT) Study	Phase 2
Completed	`NCT00622895` - Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis	Phase 1/Phase 2
Active, not recruiting	`NCT03816189` - Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
Completed	`NCT01295736` - Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY	Phase 3
Completed	`NCT02213705` - Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells	Phase 1/Phase 2
Recruiting	`NCT03508375` - Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis	N/A
Active, not recruiting	`NCT01309997` - Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease	Phase 2
Completed	`NCT00697736` - Cardiac Repercussion of Systemic Sclerodermias	N/A
Completed	`NCT02349009` - Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial	Phase 1/Phase 2
Completed	`NCT00318175` - Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis	Phase 2
Completed	`NCT03262922` - Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
Recruiting	`NCT03816345` - Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1
Recruiting	`NCT04380831` - TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis	Early Phase 1
Terminated	`NCT00628797` - Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis	Phase 1/Phase 2
Recruiting	`NCT05672992` - Longitudinal Spatial Frequency Domain Imaging Study	N/A

NCT number	NCT01410903
Study type	Interventional
Source	GWT-TUD GmbH
Contact
Status	Terminated
Phase	N/A
Start date	April 2011
Completion date	August 2012

Immunoadsorption in Patients With Severe Systemic Sclerosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms